Ryota Sagami

Dr. Ryota Sagami

Department of Gastroenterology, Oita University, Ōita, Japan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
KMKosuke Minaga
Kosuke Minaga
TOTakeshi Ogura
Takeshi Ogura
HSHideyuki Shiomi
Hideyuki Shiomi
HIHajime Imai
Hajime Imai
NHNoriyuki Hoki
Noriyuki Hoki
MKMasayuki Kitano
Masayuki Kitano
Background and Aim: Endoscopic ultrasound‐guided biliary drainage (EUS‐BD) can be carried out by two different approaches: choledochoduodenostomy (CDS) and hepaticogastrostomy (HGS). We compared the efficacy and safety of these approaches in malignant distal biliary obstruction (MDBO) patients using a prospective, randomized clinical trial.Methods: Patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography were randomly selected for either CDS or HGS. The procedures were carried out at nine tertiary centers from September 2013 to March 2016. Primary endpoint was technical success rate, and the noninferiority of HGS to CDS was examined with a one‐sided significance level of 5%, where the noninferiority margin was set at 15%. Secondary endpoints were clinical success, adverse events (AE), stent patency, survival time, and overall technical success including alternative EUS‐BD procedures.Results: Forty‐seven patients (HGS, 24; CDS, 23) were enrolled. Technical success rates were 87.5% and 82.6% in the HGS and CDS groups, respectively, where the lower limit of the 90% confidence interval of the risk difference was −12.2% (P = 0.0278). Clinical success rates were 100% and 94.7% in the HGS and CDS groups, respectively (P = 0.475). Overall AE rate, stent patency, and survival time did not differ between the groups. Overall technical success rates were 100% and 95.7% in the HGS and CDS groups, respectively (P = 0.983).Conclusions: This study suggests that HGS is not inferior to CDS in terms of technical success. When one procedure is particularly challenging, readily switching to the other could increase technical success.

20 October 2017 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
TOTakeshi Ogura
Takeshi Ogura
MKMasayuki Kitano
Masayuki Kitano
MTMamoru Takenaka
Mamoru Takenaka
AOAtsushi Okuda
Atsushi Okuda
KMKosuke Minaga
Kosuke Minaga
YCYasutaka Chiba
Yasutaka Chiba

1 August 2019 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
HHHideaki Harada
Hideaki Harada
RNRyotaro Nakahara
Ryotaro Nakahara
DMDaisuke Murakami
Daisuke Murakami
SSSatoshi Suehiro
Satoshi Suehiro
TUTetsuro Ujihara
Tetsuro Ujihara
YAYuji Amano
Yuji Amano

19 October 2020 in American Journal of Gastroenterology
Verified
Journal Article
Open access
RSRyota Sagami
Ryota Sagami
HNHidefumi Nishikiori
Hidefumi Nishikiori
TSTakao Sato
Takao Sato
HTHiroaki Tsuji
Hiroaki Tsuji
MOMasami Ono
Masami Ono
KMKazunari Murakami
Kazunari Murakami
INTRODUCTION: During the coronavirus disease 2019 pandemic, whether endoscopy generates aerosols needs to be determined. METHODS: In patients undergoing upper gastrointestinal endoscopy with an enclosure covering their heads, 0.3–10-μm aerosols were measured for 60 seconds before, during, and after endoscopy by an optical counter. Whether aerosols increased in the situation with and without endoscopy was examined. RESULTS: The analysis included 103 consecutive patients undergoing endoscopy and 90 control patients. Aerosols increased significantly during endoscopy compared with the control group. Body mass index and burping were significant factors related to increased aerosols during endoscopy. DISCUSSION: Upper gastrointestinal endoscopy was an aerosol-generating procedure.

24 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
RSRyota Sagami
Ryota Sagami
KYKentaro Yamao
Kentaro Yamao
Jun NakahodoJun Nakahodo
Jun Nakahodo
RMRYUKI MINAMI
RYUKI MINAMI
Masakatsu TsurusakiMasakatsu Tsurusaki
Masakatsu Tsurusaki
YAYuji Amano
Yuji Amano
Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions, such as pancreatic intra-epithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN). The prognosis of high-grade precancerous lesions, including high-grade PanIN and high-grade IPMN, without invasive carcinoma is good, despite the overall poor prognosis of PDAC. High-grade PanIN, as a lesion preceding invasive PDAC, is therefore a primary target for intervention. However, detection of localized high-grade PanIN is difficult when using standard radiological approaches. Therefore, most studies of high-grade PanIN have been conducted using specimens that harbor invasive PDAC. Recently, imaging characteristics of high-grade PanIN have been revealed. Obstruction of the pancreatic duct due to high-grade PanIN may induce a loss of acinar cells replaced by fibrosis and lobular parenchymal atrophy. These changes and additional inflammation around the branch pancreatic ducts (BPDs) result in main pancreatic duct (MPD) stenosis, dilation, retention cysts (BPD dilation), focal pancreatic parenchymal atrophy, and/or hypoechoic changes around the MPD. These indirect imaging findings have become important clues for localized, high-grade PanIN detection. To obtain pre-operative histopathological confirmation of suspected cases, serial pancreatic-juice aspiration cytologic examination is effective. In this review, we outline current knowledge on imaging characteristics of high-grade PanIN.

1 August 2018 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
HHHideaki Harada
Hideaki Harada
DMDaisuke Murakami
Daisuke Murakami
SSSatoshi Suehiro
Satoshi Suehiro
RNRyotaro Nakahara
Ryotaro Nakahara
TUTetsuro Ujihara
Tetsuro Ujihara
YAYuji Amano
Yuji Amano